Sp3-mediated VEGF regulation is dependent on phosphorylation by extra-cellular signals regulated kinases (Erk)

Journal of Cellular Physiology

Volumn 213, Issue 2, 2007, Pages 454-463

  Pagès, Gilles ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE DE BIOCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; RAF PROTEIN; SERINE; TAMOXIFEN; TETRACYCLINE; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CHIMERA; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GC RICH SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; CELL LINE; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; SERINE; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34848855116     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21104     Document Type: Article

References (34)

1. Bakovic M, Waite K, Vance DE. 2003. Oncogenic Ha-Ras transformation modulates the transcription of the CTP:phosphocholine cytidylyltransferase alpha gene via p42/44MAPK and transcription factor Sp3. J Biol Chem 278:14753-14761.
2. Billon N, Carlisi D, Datto MB, van Grunsven LA, Watt A, Wang XF, Rudkin BB. 1999. Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21 WAF1/CIP1 during NGF-mediaed neuronal differentiation. Oncogene 18:2872-2882.
3. Brondello JM, Pouysségur J, Mc Kenzie FR. 1999. Reduced MAP Kinase phosphatase degradation after p42/p44 MAPK-dependent phosphorylation. Science 286:2514-2517.
4. Cagnol S, Van Obberghen-Schilling E, Chambard JC. 2006. Prolonged activation of ERK1.2 induces FADD-independent caspase 8 activation and cell death. Apoptosis 11:337-346.
5. Dennig J, Beato M, Suske G. 1996. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. Embo J 15:5659-5667.
6. Gianni M, Bauer A, Garattini E, Chambon P, Rochette-Egly C. 2002. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. Embo J 21:3760-3769.
7. Gille J, Swerlick RA, Caughman SW. 1997. Transforming growth factor alpha induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2 dependent DNA binding and transactivation. EMBO J 16:750-759.
8. Hagen G, Muller S, Beato M, Suske G. 1994. Sp1-mediated transcriptional activation is repressed by Sp3. Embo J 13:3843-3851.
9. Janssen KP, el-Marjou F, Pinto D, Sastre X, Rouillard D, Fouquet C, Soussi T, Louvard D, Robine S. 2002. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. Gastroenterology 123:492-504.
10. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. 1987. Isolation of cDNA encoding transcription factor Sp-1 and functional analysis of the DNA binding domain. Cell 51:1079-1090.
11. Kennett SB, Udvadia AJ, Horowitz JM. 1997. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res 25:3110-3117.
12. Lambiase A, Merlo D, Mollinari C, Bonini P, Rinaldi AM, D'Amato M, Micera A, Coassin M, Rama P, Bonini S, Garaci E. 2005. Molecular basis for keratoconus: Lack of TrkA expression and its transcriptional repression by Sp3. Proc Natl Acad Sci USA 102:16795-16800.
13. Lee T, Hoofnagle AN, Kabuyama Y, Stroud J, Min X, Goldsmith EJ, Chen L, Resing KA, Ahn NG. 2004. Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol Cell 14:43-55.
14. Legros L, Bourcier C, Jacquel A, Mahon FX, Cassuto JP, Auberger P, Pages G. 2004. Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia. Blood 104:495-501.
15. Lenormand P, Sardet C, Pagès G, L'Allemain G, Brunet A, Pouysségur J. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45 mapkk) in fibroblasts. J Cell Biol 122:1079-1088.
16. Lenormand P, McMahon M, Pouyssegur J. 1996. Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway. J Biol Chem 271:15762-15768.
17. Marchetti S, Gimond C, Roux D, Gothie E, Pouyssegur J, Pages G. 2004. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice. J Cell Physiol 199:441-450.
18. Marchetti S, Gimond C, Chambard JC, Touboul T, Roux D, Pouyssegur J, Pages G. 2005. Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 1S9 and 197, two sites critical for its proteasomal degradation. Mol Cell Biol 25:854-864.
19. Milanini J, Vinals F, Pouysségur J, Pages G. 1998. p42/p44 MAP Kinase module plays a key role in the transcriptional regulation of vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273:18165-18172.
20. Milanini-Mongiat J, Pouyssegur J, Pages G. 2002. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: Their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639.
21. Mortensen ER, Marks PA, Shiotani A, Merchant JL. 1997. Epidermal growth factor and okadaic acid stimulate Sp1 proteolysis. J Biol Chem 272:16540-16547.
22. Murata Y, Kim HG, Rogers KT, Udvadia AJ, Horowitz JM. 1994. Negative regulation of Sp1 trans-activation is correlated with the binding of cellular proteins to the amino terminus of the Sp1 trans-activation domain. J Biol Chem 269:20674-20681.
23. Musti AM, Treier M, Bohmann D. 1997. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP Kinase. Science 275:400-402.
24. Sapetschnig A, Rischitor G, Braun H, Doll A, Schergaut M, Melchior F, Suske G. 2002. Transcription factor Sp3 is silenced through SUMO modification by PI AS1. Embo J 21:5206-5215.
25. Sapetschnig A, Koch F, Rischitor G, Mennenga T, Suske G. 2004. Complexity of translationally controlled transcription factor Sp3 isoform expression. J Biol Chem 279:42095-42105.
26. Shen T, Horwitz KB, Lange CA. 2001. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21:6122-6131.
27. Song X, Sheppard HM, Norman AW, Liu X. 1999. Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line. J Biol Chem 274:1677-1682.
28. Spengler ML, Kennett SB, Moorefield KS, Simmons SO, Brattain MG, Horowitz JM. 2005. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A insensitive mechanism. Cell Signal 17:153-166.
29. Strowski MZ, Cramer T, Schafer G, Juttner S, Walduck A, Schipani E, Kemmner W, Wessler S, Wunder C, Weber M, Meyer TF, Wiedenmann B, Jons T, Naumann M, Hocker M. 2004. Helicobacter pylori stimulates host vascular endothelial growth factor-A (vegf-A) gene expression via MEK/ERK-dependent activation of Sp1 and Sp3. Faseb J 18:218-220.
30. Suske G. 1999. The Sp-family of transcription factors. Gene 238:291-300.
31. Tamargo RJ, Bok RA, Brem H. 1991. Angiogenesis inhibition by minocycline. Cancer Res 51:672-675.
32. Tanoue T, Adachi M, Moriguchi T, Nishida E. 2000. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol 2:110-116.
33. Verger A, Perdomo J, Crossley M. 2003. Modification with SUMO. A role in transcriptional regulation. EMBO Rep 4:137-142.
34. Vial E, Marshall CJ. 2003. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 116:4957-4963.